Advertisement

Topics

Rett Syndrome Drug Could Propel Newron To Next Level In 2018

11:08 EDT 8 Aug 2017 | SCRIP

Newron Pharmaceuticals will file its investigational drug sarizotan in 2018 for respiratory issues in patients with Rett syndrome, setting it...

      

Related Stories

 

Original Article: Rett Syndrome Drug Could Propel Newron To Next Level In 2018

NEXT ARTICLE

More From BioPortfolio on "Rett Syndrome Drug Could Propel Newron To Next Level In 2018"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...